Nessa Carey

Nessa Carey is a British biologist working in the field of molecular biology and biotechnology.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 3 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Nessa Carey is a British biologist working in the field of molecular biology and biotechnology. She is International Director of the technology transfer organization PraxisUnico and a visiting professor at Imperial College London.

With expertise in the field of epigenetics and in technology transfer, she promotes the movement of scientists between academia and industry, lecturing often to students and early career scientists. Carey writes books and articles for a scientifically interested general audience.

She is the author of The Epigenetics Revolution and Junk DNA: A Journey Through the Dark Matter of the Genome which explore advances in the field of epigenetics and their implications for medicine. She edited Epigenetics for Drug Discovery for the Royal Society of Chemistry's Drug Discovery Series.

Epigenetics for Drug Discovery

Edited by Carey, Epigenetics for Drug Discovery, is "written by the leading researchers in this field. It is intended as a guide for medicinal chemists or scientists in other fields wishing to know more." This book examines the field of epigenetics, its possible applications to medicine and the challenges in using the research safely and efficaciously.

It includes for example: a chapter by Karl P. Nightingale which defines epigenetics and explains why it matters; a chapter by Tom D. Heightman and Michael McCullar which focuses "on the biochemical mechanisms controlling DNA methylation, consequences of aberrant DNA methylation in complex chronic diseases, existing modulators of DNA methylation used in the clinic, and opportunities for new drugs targeting this central epigenetic mechanism" and a chapter titled "Progress in Targeting Epigenetic Readers" by Chun-Wa Chung. This book is part of the Royal Society of Chemistry's Drug Discovery Series which includes over fifty volumes published since 20101 in the fields of drug discovery and medicinal chemistry.

"Providing comprehensive coverage of this important and far-reaching area, the books encourage learning in a range of different topics and provide valuable reference for scientists working outside their own areas of expertise."

Hacking the Code of Life: How Gene Editing Will Rewrite Our Futures (2019)

This book discusses a new technique for genetic modification called CRISPR. This system allows the scientists to precisely and easily manipulate the genes of any living organism in a short period of time. The book further discusses the ethical limitations in the implementation of these methods on human beings. Carey gives a snapshot of the technology that is possibly going to change the future of gene editing.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1372255233 under CC BY-SA 4.0; modifications have been made.

References

  1. ↩Wikipedia “Nessa Carey” revision 1372255233 · retrieved 2026-10-20 publication date (×1) · confidence 0.95 revision URL